OncoTargets and Therapy
Volume 10, 2017 - Issue
Open access
59
Views
7
CrossRef citations to date
0
Altmetric
Original Research
Characteristics and mutation analysis of Ph-positive leukemia patients with T315I mutation receiving tyrosine kinase inhibitors
Peipei Xu1 Department of Hematology, Drum Tower Hospital, School of Medicine, Nanjing University
, Dan Guo2 Department of Hematology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, People’s Republic of China
, Xiaoyan Shao1 Department of Hematology, Drum Tower Hospital, School of Medicine, Nanjing University
, Miaoxin Peng1 Department of Hematology, Drum Tower Hospital, School of Medicine, Nanjing University
& Bing Chen2 Department of Hematology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, People’s Republic of ChinaCorrespondence[email protected]
Pages 4731-4738
|
Published online: 25 Sep 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.